bullish
New Horizon IPO: Leaning Positive
612 Views30 Dec 2020 21:52
New Horizon Health is a cancer diagnostics company that plans to list on the HKEX. The company has innovative tests for CRC, gastric, and potentially cervical cancer. We view the company favorably.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 8-minute read)
Discussions
(Paid Plans Only)
Kemp Dolliver, CFA
Founder
Price Chart(Sign Up to Access)
- New Horizon IPO: Only Undemanding Assumptions Needed07 Feb 2021
- New Horizon IPO: Leaning Positive30 Dec 2020
- Asian Healthcare - Coming of Age26 Nov 2020
- New Horizon Health (诺辉健康) Pre-IPO: A Hot Medical Device Deal in Making26 Nov 2020
- Autonomous Driving- Are We There Yet?20 Mar 2018
x